CD200 and breast carcinoma: Further, the role of CD200 in metastasis in breast cancers was demonstrated in studies showing that the neutralization of CD200 by monoclonal anti-CD200 antibodies decreases tumor metastases and was associated with increased cytotoxic antitumor immune cell flux into the regional lymph nodes [36].